Concepedia

Hong Wan

HW

Statistics

Publications

13

Citations

564

H-Index

12

Active since

2005

Affiliations

Collaborative Drug Discovery (United States)(Current)

South Texas Accelerated Research Therapeutics

Start Treatment & Recovery Centers

Samsung Medical Center

University of Colorado Denver

Hong Wan is an author at Collaborative Drug Discovery (United States) specializing in medicine, immunology, and tumor immunity.

ORCID

Top concepts

Publications per year

2005–2021

13

Publications

13

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile

Steven E. Kauder, Tracy C. Kuo, Ons Harrabi et al. · PLoS ONE · 2018 · 164 citations · Full text

, , +18

Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection

Peter Bergman, Linda Johansson, Hong Wan et al. · Infection and Immunity · 2006 · 87 citations · Full text

, , +21

Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity

Tracy C. Kuo, Amy Chen, Ons Harrabi et al. · Journal of Hematology & Oncology · 2020 · 69 citations · Full text

Discovery of high affinity, pan-allelic, and pan-mammalian reactive antibodies against the myeloid checkpoint receptor SIRPα

Janet Sim, Jonathan T. Sockolosky, Emma Sangalang et al. · mAbs · 2019 · 48 citations · Full text

Human-Like Immune Responses in CD46 Transgenic Mice

Linda Johansson, Anne Rytkönen, Hong Wan et al. · The Journal of Immunology · 2005 · 45 citations

1–5 of 13